| 靶点: |
KI: 8.6 μM (PFKFB4) |
| 体内研究: |
5MPN (120 mg/kg; p.o.) suppresses the growth of Lewis lung carcinomas (LLC) grown in syngeneic mice and H460 human lung adenocarcinoma xenografts grown in athymic mice without affecting body weight. 5MPN causes a reduction in Ki67-positive cells in the LLC xenografts suggesting that 5MPN may be reducing cell cycle progression in vivo. |
| 参考文献: |
1. Chesney J, et al. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor. Oncotarget. 2015;6(20):18001-18011. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.275 ml |
16.376 ml |
32.751 ml |
| 5 mM |
0.655 ml |
3.275 ml |
6.55 ml |
| 10 mM |
0.328 ml |
1.638 ml |
3.275 ml |
| 50 mM |
0.066 ml |
0.328 ml |
0.655 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |